Small B-Cell Lymphomas COPY Flashcards
Monocyte markers?
CD45+, CD14+, CD114+, CD11a+, CD11b, CD16+, CD91+
B-cell markers?
CD45+, CD19+, CD20+, CD24+, CD38+, CD22+, PAX5+, CD79a+
NK Cell Markers
CD16+, CD56+, CD3-, CD31+, CD30+, CD38+
Pro B Markers (B-ALL)
Tdt+, Cd34+, CD19+, CD10+, PAX5+/-, CD20-
Pre-B Markers (B-ALL)
Has Pre BCR
Tdt+, CD34+, CD19+, CD10+, PAX5+ (different from Pro B), CD79a+, CD20-
Immature B-cell (B-ALL)
Tdt+/- (pre B and Pro B +)
CD34+/- (pre B and Pro B +)
CD20+ (pre B and Pro B +)
CD19+
CD10+
PAX5+
CD79a+
Has some surface IgM
Naive B (incluidng Ig types) 2 Cancers with this pheonotype?
IgM and D
TdT-
CD10+ (first time this is positive)
PAX5+
CD20+
CD79a+
Burkitt Lymphoma and Mantle
Centroblast (Phenotype and 1 associated cancer with phenotype)
CD19+
CD10+
PAX5+
CD20+
CD79a+
BCL6+ (normally found inside germinal centers)
High grade follicular lymphoma
Small Cell Lymphoma CD5+ CD10+?
CD5- CD10+?
CD5- and CD10-?
CD5+ CD10+= CLL (CD23+) or Mantle (Cyclin D1 +, CD23-)
Follicular (CD5-, CD10+)
Marginal Zone and Lymphoplasma Cytic
Post-transplant lymphoproliferatrive disorder associated diseases (and viral cause)?
EBV+
Non-=destructive PTLD, polymorphic PTLD, monomorphic PTLD, Classic Hodgkin lymphoma PTLD
HIV related lymphomas
Burkitt
Diffuse large B-cell lymphoma
Primary effusion
Plasmablastic lymphoma
Lymphoma from HHV8+ Castleman
CLL/SLL Phenotype
Classic Cell Morphology and Classic “finding”
CD19+, DIM CD20+, CD22+, CD79+, Dim IgM/D, CD5+, CD23+
CD10-, FMC7-, CyclinD1-
Clumped chromatin, scant cytoplasm (Soccer ball)
Diffuse effacement with Proliferation Centers (lack Tingible body macrophages)
Small lymphocytes, prolymphocytes, and paraimmunoblasts
CLL transformation into DLBCL called?
Good vs Bad CLL Prognosis genes
Richter syndrome (DLBCL) 2-8%, <1% into Hodgkin
Good: Mutated IGHV, Memory Like Cases, Isolated 13q14
Bad: Unmutated, Zap70+, CD38+ CD49d+, Del 11q or 17p, 13q, and more
What is Monoclonal B lymphocytosis?
Clonal B-cells with CLL phenotype
Low count: <0.5e9/L, insignificant
High: >0.5e9/L, 1-2% CLL/yr
B-cell Prolymphocytic leukemia (Surface antigens, affected gene, surface antigens)
- *CLL with Prolymphocytes**
- *t(11;14) or SOX11-**leukemic variant MCL
IgM/IgD, CD5+/CD23+ 25% of cases